Current Net Margin
—
INmune Bio, Inc. currently has a net profit margin of —.
Financial Fundamentals
INMB • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.01 | — | — |
| 2025-09-30 | 0.00 | -0.01 | — | — |
| 2025-06-30 | 0.00 | -0.02 | — | — |
| 2025-03-31 | 0.00 | -0.01 | -19478.00% | — |
| 2024-12-31 | 0.00 | -0.01 | — | — |
| 2024-09-30 | 0.00 | -0.01 | — | — |
| 2024-06-30 | 0.00 | -0.01 | — | — |
| 2024-03-31 | 0.00 | -0.01 | -78750.00% | ▼4872143 |
| 2023-12-31 | 0.00 | -0.01 | -30028.57% | ▼1011462 |
| 2023-09-30 | 0.00 | -0.01 | -19913.95% | ▼578134 |
| 2023-06-30 | 0.00 | -0.01 | -14132.61% | ▲306739 |
| 2023-03-31 | 0.00 | -0.01 | -17200.00% | ▼1118660 |
| 2022-12-31 | 0.00 | -0.01 | -6013.40% | ▲186925 |
| 2022-09-30 | 0.00 | -0.01 | -7882.65% | ▲3485485 |
| 2022-06-30 | 0.00 | -0.01 | -42737.50% | ▼3850253 |
| 2022-03-31 | 0.00 | -0.01 | -4234.97% | ▲169816 |
| 2021-12-31 | 0.00 | -0.01 | -5933.13% | ▲6162401 |
| 2021-09-30 | 0.00 | -0.01 | -67557.14% | — |
| 2021-06-30 | 0.00 | -0.01 | — | — |
| 2021-03-31 | 0.00 | -0.00 | -113900.00% | ▼8477273 |
| 2020-12-31 | 0.00 | -0.00 | -29127.27% | — |
| 2020-09-30 | 0.00 | -0.00 | — | — |
| 2020-06-30 | 0.00 | -0.00 | — | — |
| 2020-03-31 | 0.00 | -0.00 | — | — |
| 2019-12-31 | 0.00 | -0.00 | — | — |
| 2019-09-30 | 0.00 | -0.00 | — | — |
| 2019-06-30 | 0.00 | -0.00 | — | — |
| 2019-03-31 | 0.00 | -0.00 | — | — |
| 2018-12-31 | 0.00 | -0.00 | — | — |
| 2018-09-30 | 0.00 | -0.00 | — | — |
| 2018-06-30 | 0.00 | -0.01 | — | — |
| 2018-03-31 | 0.00 | -0.00 | — | — |
| 2017-12-31 | 0.00 | -0.00 | — | — |
| 2017-09-30 | 0.00 | -0.00 | — | — |
| 2017-06-30 | 0.00 | -0.00 | — | — |
| 2017-03-31 | 0.00 | 0.00 | — | — |
| 2016-12-31 | 0.00 | -0.00 | — | — |
| 2016-09-30 | 0.00 | -0.00 | — | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.